10x Genomics, Inc.
TXG
Price:
$20.22
Market Cap:
$2.42B
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics compris...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2019-09-12
Stock Exchange
NASDAQ
Ticker
TXG
The PE Ratio as of July 2024 (TTM) for 10x Genomics, Inc. (TXG) is -9.03
According to 10x Genomics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.03. This represents a change of -60.52% compared to the average of -22.87 of the last 4 quarters.
10x Genomics, Inc. (TXG) Historical PE Ratio (quarterly & annually)
How has TXG PE Ratio performed in the past?
The mean historical PE Ratio of 10x Genomics, Inc. over the last ten years is -70.51. The current -9.03 PE Ratio has changed 1.18% with respect to the historical average. Over the past ten years (40 quarters), TXG's PE Ratio was at its highest in in the December 2018 quarter at -2.45. The PE Ratio was at its lowest in in the June 2021 quarter at -486.65.
Average
-70.51
Median
-26.39
Minimum
-282.32
Maximum
-6.28
10x Genomics, Inc. (TXG) PE Ratio by Quarter and Year
Discovering the peaks and valleys of 10x Genomics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.42%
Maximum Annual PE Ratio = -6.28
Minimum Annual Increase = -91.15%
Minimum Annual PE Ratio = -282.32
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -25.70 | 2.83% |
| 2022 | -24.99 | -91.15% |
| 2021 | -282.32 | 969.76% |
| 2020 | -26.39 | -72.31% |
| 2019 | -95.31 | 1.42% |
| 2018 | -6.28 | -80.72% |
10x Genomics, Inc. (TXG) Average PE Ratio
How has TXG PE Ratio performed in the past?
The current PE Ratio of 10x Genomics, Inc. (TXG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-111.00
5-year avg
-90.94
10-year avg
-70.51
10x Genomics, Inc. (TXG) PE Ratio vs. Peers
How is TXG’s PE Ratio compared to its peers?
10x Genomics, Inc.’s PE Ratio is greater than Twist Bioscience Corporation (-17.47), less than Fate Therapeutics, Inc. (-2.89), greater than Beam Therapeutics Inc. (-20.09), greater than Veracyte, Inc. (-26.01), less than Guardant Health, Inc. (-8.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| -17.47 | $3.38B | |
| -2.89 | $619.25M | |
| -20.09 | $2.73B | |
| -26.01 | $1.81B | |
| -8.71 | $4.04B |
Build a custom stock screener for 10x Genomics, Inc. (TXG) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 10x Genomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
10x Genomics, Inc. (TXG) and other stocks custom spreadsheet templates
The easiest way to analyze a company like 10x Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is 10x Genomics, Inc.'s PE Ratio?
How is the PE Ratio calculated for 10x Genomics, Inc. (TXG)?
What is the highest PE Ratio for 10x Genomics, Inc. (TXG)?
What is the 3-year average PE Ratio for 10x Genomics, Inc. (TXG)?
What is the 5-year average PE Ratio for 10x Genomics, Inc. (TXG)?
How does the current PE Ratio for 10x Genomics, Inc. (TXG) compare to its historical average?